Androgen-receptor positive lacrimal sac adenocarcinoma demonstrating long-lasting response to LHRH analogue plus abiraterone treatment

Androgen-receptor positive lacrimal sac adenocarcinoma demonstrating long-lasting response to LHRH analogue plus abiraterone treatment

Tumors arising at the lacrimal sac are extremely rare, as a limited number of cases have been reported worldwide. They are commonly primary and the majority of them are malignant and epithelial in origin. Adenocarcinomas account for a small percentage of these tumors. Treatment of local disease main...

Full description

Bibliographic Details
Main Authors: Elena eVagia, Panagiota eEconomopoulou, Nikolaos eOikonomopoulos, Ilias eAthanasiadis, George eDimitriadis, Amanda ePsyrri
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-02-01
Series:Frontiers in Oncology
Subjects:
Adenocarcinoma
abiraterone
androgen receptor
molecular target
Lacrimal sac
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2015.00010/full

Similar Items

Similar Items